ACUTE BIPHENOTYPIC LEUKEMIA
Clinical trials for ACUTE BIPHENOTYPIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE BIPHENOTYPIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE BIPHENOTYPIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Frozen bone marrow transplants aim to help blood cancer patients
Disease control TerminatedThis study planned to test whether banked, frozen bone marrow from partially matched donors could be safely used for transplants in people with blood cancers like leukemia. Participants would have received a transplant followed by drugs to prevent graft-versus-host disease. The s…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control OngoingThis study tests whether two drugs, venetoclax and azacitidine, can help prevent leukemia from returning in 100 adults who have already had a stem cell transplant. Participants must be between 18 and 75 years old and in remission after transplant. The goal is to see if this combi…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Engineered t cells take aim at Hard-to-Treat leukemias
Disease control OngoingThis early-phase study tests a new type of immunotherapy for people with certain leukemias that have come back or not responded to standard treatments. The therapy uses a patient's own or a donor's immune cells that are genetically modified to recognize and attack cancer cells ca…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 05, 2026 11:52 UTC